Glassman Wealth Services Iovance Biotherapeutics, Inc. Transaction History

Glassman Wealth Services

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$3.3 - $8.89 $386 - $1,040	117 New	117 $0
Q2 2022 Aug 04, 2022	BUY	$6.38 - $18.33 $1,875 - $5,389	294 Added 110.53%	560 $6,000
Q1 2022 Apr 14, 2022	BUY	$12.38 - $19.1 $3,293 - $5,080	266 New	266 $4,000
Q4 2021 Feb 14, 2022	SELL	$16.55 - $27.63 $7,944 - $13,262	-480 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$20.35 - $26.63 $9,768 - $12,782	480 New	480 $12,000
Q2 2021 Aug 04, 2021	SELL	$16.33 - $33.07 $4,360 - $8,829	-267 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$28.67 - $52.59 $487 - $894	17 Added 6.8%	267 $8,000
Q4 2020 Feb 04, 2021	BUY	$28.04 - $50.26 $7,010 - $12,565	250 New	250 $12,000
Q1 2020 May 12, 2020	SELL	$19.54 - $38.85 $58 - $116	-3 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$17.99 - $26.0 $53 - $78	3 New	3 $0

320

239M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $958M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.